Lilly Links Bonuses To R&D Output | February 14, 2011 Issue - Vol. 89 Issue 7 | Chemical & Engineering News
Volume 89 Issue 7 | p. 19 | Concentrates
Issue Date: February 14, 2011

Lilly Links Bonuses To R&D Output

Department: Business
Keywords: R&D, compensation

Eli Lilly & Co. has altered its compensation scheme for 2011 and 2012 to tie employee bonuses to the success of its new-drug pipeline. To do this, the company has introduced a “research metric” to track the output of its R&D engine. In addition to keeping tabs on the number of new-product approvals and compounds that move into Phase III trials, Lilly is monitoring the progress of projects as they hit research milestones. Acknowledging the firm’s business challenges, CEO John C. Lechleiter has asked that he receive no compensation increase in 2011.

 
Chemical & Engineering News
ISSN 0009-2347
Copyright © American Chemical Society

Leave A Comment

*Required to comment